Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
2017 · The Lancet Oncology · 504 citations
https://doi.org/10.1016/s1470-2045(17)30243-7
S
Stephen Crosier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
1.9K
Citations
14
h-index
17
i10-index
Stephen Crosier is an academic researcher from Newcastle University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Chromatin Remodeling and Cancer & Cancer Genomics and Diagnostics. The author has an h-index of 14, co-authored 68 publications.
Papers by this author
worksPediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
2020 · Nature Communications · 227 citations
https://doi.org/10.1038/s41467-020-18070-y
Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
2014 · Cancer Cell · 205 citations
https://doi.org/10.1016/j.ccell.2014.11.002
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
2022 · Cell Reports · 72 citations
https://doi.org/10.1016/j.celrep.2022.111162
Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
2016 · Cell Reports · 56 citations
https://doi.org/10.1016/j.celrep.2016.10.005
The proteomic landscape of soft tissue sarcomas
2023 · Nature Communications · 41 citations
https://doi.org/10.1038/s41467-023-39486-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat